IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effects, both good and bad, of IPX056 on
subjects and their spasticity. This study will also determine the relationship between the
amount of IPX056 in blood and the effects on spasticity. Lastly, this study will determine
how long IPX056 affects spasticity.